A Phase I Study to Assess the Safety and Immunogenicity of AdCh3NSmut and MVA-NSmut in Healthy Volunteers and Patients With Hepatitis C Virus Infection

Trial Profile

A Phase I Study to Assess the Safety and Immunogenicity of AdCh3NSmut and MVA-NSmut in Healthy Volunteers and Patients With Hepatitis C Virus Infection

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jul 2016

At a glance

  • Drugs Hepatitis C vaccine (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Sponsors ReiThera
  • Most Recent Events

    • 24 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 23 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to United Kingdom Clinical Research Network record.
    • 02 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top